Can menopause, oestrogen levels, and hormonal shifts influence brain health for women with Parkinson's?

Research is increasingly highlighting the complex relationship between hormonal changes and brain health, particularly how the decline of oestrogen during menopause may influence the risk of developing Parkinson’s. Dr Sudeshna Ray, a gynaecologist at Jaslok Hospital and Research Centre, recently discussed how oestrogen acts as a natural shield for the brain. This "neuroprotective" quality helps maintain healthy neurons and supports the production of dopamine, the chemical often depleted in those living with Parkinson’s. When oestrogen levels drop significantly during and after menopause, the brain loses this natural layer of protection. Dr Ray explains that this decline can trigger inflammatory responses and oxidative stress, both of which are linked to the gradual damage of brain cells. For some women, this hormonal shift may potentially unmask or accelerate the progression of neurodegenerative conditions. This connection helps explain why Parkinson’s symptoms can sometimes fluctuate or become more pronounced during periods of hormonal transition. One area of significant interest is Hormone Replacement Therapy (HRT) and its potential role in mitigating these risks. Some studies suggest that HRT, particularly when started early in the menopausal transition, may support cognitive function and offer some protection against the loss of dopamine-producing cells. However, the scientific community remains cautious. While the benefits for bone health and the relief of menopausal symptoms like hot flushes are well-documented, the impact of HRT on Parkinson's risk is still being debated, with results from various trials appearing inconsistent. It is vital to recognise that HRT is not a universal solution and carries its own set of medical considerations. While modern preparations, such as transdermal patches and gels, are generally considered safer than older oral versions, there are still risks that must be weighed. For instance, long-term use of combined HRT has been associated with a slight increase in the risk of breast cancer. There are also rare but important risks concerning blood clots and stroke, particularly for those starting therapy later in life or those with pre-existing cardiovascular issues. Given these complexities, any decision regarding hormone therapy must be highly personalised. It is essential to discuss these options with a GP or specialist who can assess your individual health history, including any family history of cancer or heart health concerns. While understanding the link between oestrogen and brain health provides valuable insight, hormone therapy should only be considered as part of a broader, medically supervised plan tailored to your specific needs. For those looking to learn more about the interaction between hormones and brain health, the Parkinson’s Insights webinars section on YouTube features an insightful session titled "Women with Parkinson's and Menopause," which includes an interview with Dr Tanya Denne.